Results 71 to 80 of about 98,210 (227)

Kinetics of the Exchange Reactions between Gd(DTPA)²⁻, Gd(BOPTA)²⁻, and Gd(DTPA-BMA) Complexes, Used As MRI Contrast Agents, and the Triethylenetetraamine-Hexaacetate Ligand

, 2016
The kinetics of ligand exchange reactions occurring between the Gd(DTPA), Gd(BOPTA), and Gd(DTPA-BMA) complexes, used as contrast agents in MRI, and the ligand TTHA, have been studied in the pH range 6.5−11.0 by measuring the water proton relaxation ...
Ernő Brücher (1833031), Zoltán Pálinkás (2207905), Zsolt Baranyai (390062), Béla Rózsa (2207908)   +3 more
core   +1 more source

Mannose-coated gadolinium liposomes for improved magnetic resonance imaging in acute pancreatitis

International Journal of Nanomedicine, 2017
Bing Tian,1 Ri Liu,1 Shiyue Chen,1 Luguang Chen,1 Fang Liu,1 Guorong Jia,1 Yinmei Dong,1 Jing Li,1 Huaiwen Chen,2,3 Jianping Lu11Department of Radiology, 2Center of Clinical and Translational Medicine, Shanghai Changhai Hospital, The Second Military ...
Tian B, Liu R, Chen S, Chen L, Liu F, Jia G, Dong Y, Li J, Chen H, Lu J   +9 more
doaj  

Quantum Dots for Biomedical Biosensing, NIR‐II Bioimaging, and Phototherapy: Materials Design, Signal Transduction, and Translational Barriers

Advanced Science, Volume 13, Issue 33, 15 June 2026.
This review outlines bottom‐up and biomimetic fabrication strategies of quantum dots, and highlights their emerging applications in biosensing, multimodal bioimaging, and intelligent cancer theranostics. It further discusses key translational barriers and future perspectives for advancing QD‐based nanomedicine toward clinical implementation.
Jie Ju, Zhifang Liu, Xinran Gao, Wen Sun, Wei Fu, Yanfei Wang   +5 more
wiley   +1 more source

Einfluss der Feldstärke auf die Magnetresonanzangiographie:Vergleich des leberspezifischen Kontrastmittels Gd-EOB-DTPA mit Gd-DTPA an Kaninchen bei 1,5 und 3 Tesla

, 2009
Ziel dieser Tierstudie war es, das Kontrastmittel Gd-EOB-DTPA hinsichtlich seiner angiographischen Eigenschaften für die CE-MRA im Vergleich zum Kontrastmittel Gd-DTPA bei den Feldstärken 1,5 und 3 Tesla zu untersuchen.
Wieloch, N. (Nora)
core   +1 more source

Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles

, 2007
In this paper we report the preparation and characterization of [Gd(dtpa)](2-) intercalated layered double hydroxide (LDH) nanomaterials. [Gd(dtpa)](2-) (gadolinium(III) diethylene triamine pentaacetate) was transferred into LDH by anionic exchange.
Xu, Zhi Ping, Kurniawan, Nyoman D., Bartlett, Perry F., Lu, Gao Qing   +3 more
core   +1 more source

Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR

Journal of Cardiovascular Magnetic Resonance, 2010
Background Standard extracellular cardiovascular magnetic resonance (CMR) contrast agents (CA) do not provide differentiation between acute and older myocardial infarcts (MI).
Ruzsics Balazs, Kiss Pal, Suranyi Pal, Simor Tamas, Varga-Szemes Akos, Toth Levente, Kirschner Robert, Toth Attila, Baker Robert, Brott Brigitta C, Litovsky Silvio, Elgavish Ada, Elgavish Gabriel A   +12 more
doaj   +1 more source

MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Objective This study aimed to develop and validate an MRI‐based DeltaHabitat radiomics model to predict pathological complete response (pCR) in oral cavity squamous cell carcinoma (OCSCC) patients treated with neoadjuvant chemoimmunotherapy. Methods Patients treated with neoadjuvant chemoimmunotherapy and surgery were retrospectively included ...
Lin Ding, Jialing Wu, Yangxin Liang, Jiaxuan Ding, Shu Zhou, Liting Li, Lehang Lin, Jiale Zeng, Changlong Chen   +8 more
wiley   +1 more source

c‐Met‐Targeted Imaging Agents: Progress and Challenges

iRADIOLOGY, Volume 4, Issue 3, Page 219-245, June 2026.
This review summarizes recent advances in c‐Met‐targeted imaging probes, including hepatocyte growth factor (HGF) ligands, antibodies, peptides, and small molecules across magnetic resonance imaging (MRI), positron emission tomography (PET), single‐photon emission computed tomography (SPECT), and optical imaging modalities.
Yonghao Li, Aiyan Ji, Qihang Ding, Hongyue Lou, Zhen Cheng   +4 more
wiley   +1 more source

In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma. [PDF]

, 2001
New tumor-specific contrast agents for clinical imaging and therapy for cancer are required. To this end Gd-H (Gd-hematoporphyrin), Gd-TCP (Gd-tetra-carboranylmethoxyphenyl-porphyrin), Gd-DTPA-WM53, and Gd-DTPA-9.2.27 were synthesized and administered by
S. Rizvi, Rizvi, S., M. Williams, Allen, B., D. Shahbazi‐Gahrouei, Shahbazi-Gahrouei, D., Williams, M., B. J. Allen   +7 more
core   +1 more source

Impact of Frequent Immune‐Mediated Adverse Events on Treatment Continuity and Outcomes During Durvalumab Plus Tremelimumab Therapy for Unresectable Hepatocellular Carcinoma

Liver International Communications, Volume 7, Issue 2, June 2026.
ABSTRACT Durvalumab plus tremelimumab (Dur/Tre) is the first‐line treatment for unresectable hepatocellular carcinoma (uHCC). Immune‐mediated adverse events (imAEs) are common; however, the impact of specific imAE types on treatment persistence and outcomes remains unclear.
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Takanori Matsuura, Yoshihide Ueda, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, on behalf of the RELPEC Group and HCC 48 Group   +53 more
wiley   +1 more source